Education
About Us
Working with TipRanks
Follow Us
Novaccess Global Inc (XSNX)
:XSNX
XSNX Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume289.00
Average Volume (3M)36.23K
Market Cap
$18.57K
Enterprise Value$2.11M
Total Cash (Recent Filing)$794.00
Total Debt (Recent Filing)$2.09M
Price to Earnings (P/E)―
Beta26.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding61,906,933
10 Day Avg. Volume19,162
30 Day Avg. Volume36,228
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00
P/FCF Ratio-0.08
Enterprise Value/Market Cap113.40
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NovAccess Global News
PremiumCompany Announcements
Neil Laird Exits NovAccess Global, Joins Ondas Holdings
PremiumCompany Announcements
NovAccess Global Faces Default and Uncertain Rescue Deal
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
XSNX FAQ
What was Novaccess Global Inc’s price range in the past 12 months?
Novaccess Global Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Novaccess Global Inc’s market cap?
Novaccess Global Inc’s market cap is $18.57K.
When is Novaccess Global Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Novaccess Global Inc’s earnings last quarter?
Currently, no data Available
Is Novaccess Global Inc overvalued?
According to Wall Street analysts Novaccess Global Inc’s price is currently Overvalued.
Does Novaccess Global Inc pay dividends?
Novaccess Global Inc does not currently pay dividends.
What is Novaccess Global Inc’s EPS estimate?
Novaccess Global Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Novaccess Global Inc have?
Novaccess Global Inc has 61,906,933 shares outstanding.
What happened to Novaccess Global Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Novaccess Global Inc?
Currently, no hedge funds are holding shares in XSNX
Company Description
Novaccess Global Inc
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
Biodexa Pharmaceuticals
―
Salarius Pharmaceuticals
―
Processa Pharmaceuticals
―
GRI Bio
―
Onconetix
―